The University of Southampton
University of Southampton Institutional Repository

Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine

Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine

Rats were treated continuously for 12 months with therapeutically equivalent doses of either haloperidol (1.4-1.6 mg/kg/day), sulpiride (102-109 mg/kg/day), or clozapine (24-27 mg/kg/day). After treatment for 3 and 12 months with haloperidol or clozapine but not sulpiride, striatal acetylcholine levels were increased. Striatal choline acetyltransferase activity was not altered by any drug treatment. V(max) for striatal acetylcholinesterase activity during the course of 12 months' treatment with haloperidol or clozapine, but not with sulpiride, tended to increase; K(m) was not altered by any drug treatment. B(max) for specific striatal [3H]quinuclidinyl benzilate binding was not altered by haloperidol or sulpiride treatment but was transiently elevated after 6 months of clozapine treatment, thereafter returning to control levels. K(d) was not altered by any drug treatment. These findings indicate that alterations in striatal acetylcholine content caused by chronic treatment with some but not all neuroleptics are due to changes in cholinergic neuronal activity rather than neurotransmitter synthesis or destruction. The effects of haloperidol but not those of clozapine may be related to the emergence of functional striatal dopamine receptor supersensitivity. Since haloperidol (which is associated with a high prevalence of tardive dyskinesias) but not clozapine (which is not) had similar effects on striatal cholinergic function, the latter may not be related to the emergency of tardive dyskinesias during chronic therapy.

0362-5664
282-292
Rupniak, N. M.J.
043ae8d6-a074-46a7-a8d1-2fef1749b647
Briggs, R. S.
a6b65ef0-e90c-4c07-bf5b-b70130c128b3
Petersen, M. M.
43045e58-dcf0-4245-a69e-c039f18b8f6e
Mann, S.
feac17d6-0a57-4673-a406-f8dbcaee54e7
Reavill, C.
8c5c0602-3c28-4a2b-af80-f6ec52040f04
Jenner, P.
785c25df-ec64-4181-b057-26dd31cd9d84
Marsden, C. D.
ccd1ecc8-3eb4-4699-a87e-0bfba0dd40b0
Rupniak, N. M.J.
043ae8d6-a074-46a7-a8d1-2fef1749b647
Briggs, R. S.
a6b65ef0-e90c-4c07-bf5b-b70130c128b3
Petersen, M. M.
43045e58-dcf0-4245-a69e-c039f18b8f6e
Mann, S.
feac17d6-0a57-4673-a406-f8dbcaee54e7
Reavill, C.
8c5c0602-3c28-4a2b-af80-f6ec52040f04
Jenner, P.
785c25df-ec64-4181-b057-26dd31cd9d84
Marsden, C. D.
ccd1ecc8-3eb4-4699-a87e-0bfba0dd40b0

Rupniak, N. M.J., Briggs, R. S., Petersen, M. M., Mann, S., Reavill, C., Jenner, P. and Marsden, C. D. (1986) Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine. Clinical Neuropharmacology, 9 (3), 282-292. (doi:10.1097/00002826-198606000-00006).

Record type: Article

Abstract

Rats were treated continuously for 12 months with therapeutically equivalent doses of either haloperidol (1.4-1.6 mg/kg/day), sulpiride (102-109 mg/kg/day), or clozapine (24-27 mg/kg/day). After treatment for 3 and 12 months with haloperidol or clozapine but not sulpiride, striatal acetylcholine levels were increased. Striatal choline acetyltransferase activity was not altered by any drug treatment. V(max) for striatal acetylcholinesterase activity during the course of 12 months' treatment with haloperidol or clozapine, but not with sulpiride, tended to increase; K(m) was not altered by any drug treatment. B(max) for specific striatal [3H]quinuclidinyl benzilate binding was not altered by haloperidol or sulpiride treatment but was transiently elevated after 6 months of clozapine treatment, thereafter returning to control levels. K(d) was not altered by any drug treatment. These findings indicate that alterations in striatal acetylcholine content caused by chronic treatment with some but not all neuroleptics are due to changes in cholinergic neuronal activity rather than neurotransmitter synthesis or destruction. The effects of haloperidol but not those of clozapine may be related to the emergence of functional striatal dopamine receptor supersensitivity. Since haloperidol (which is associated with a high prevalence of tardive dyskinesias) but not clozapine (which is not) had similar effects on striatal cholinergic function, the latter may not be related to the emergency of tardive dyskinesias during chronic therapy.

This record has no associated files available for download.

More information

Published date: 1986

Identifiers

Local EPrints ID: 479116
URI: http://eprints.soton.ac.uk/id/eprint/479116
ISSN: 0362-5664
PURE UUID: 89a185bb-6f33-4a04-89b8-31644e0ee349

Catalogue record

Date deposited: 20 Jul 2023 16:36
Last modified: 17 Mar 2024 03:36

Export record

Altmetrics

Contributors

Author: N. M.J. Rupniak
Author: R. S. Briggs
Author: M. M. Petersen
Author: S. Mann
Author: C. Reavill
Author: P. Jenner
Author: C. D. Marsden

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×